Background
==========

Gait analysis equipment using a computer has been used increasingly by clinicians to obtain objective and accurate measurements of spatio-temporal gait patterns \[[@b1-medscimonit-20-1210],[@b2-medscimonit-20-1210]\]. In particular, the advent of modern and portable instrument walkway systems induced rapid determination of the spatio-temporal gait parameters during over-ground walking \[[@b3-medscimonit-20-1210]--[@b5-medscimonit-20-1210]\]. On the other hand, assessing the gait pattern during over-ground walking is limited by the instrumented walkway length and limited working space.

Treadmill gait analysis has been considered more advantageous than over-ground walking because it required less space and allowed continuous measurements of the gait parameters. Moreover, intervention effects could be compared under equivalent conditions by the constant walking speed at pre- and post-test \[[@b6-medscimonit-20-1210]--[@b8-medscimonit-20-1210]\]. Treadmill walking encourages repetitive and intensive gait training and facilitates a normal gait pattern. Therefore, it is considered a viable intervention for treating gait impairments associated with neurological disorders such as Parkinson's disease \[[@b9-medscimonit-20-1210]--[@b11-medscimonit-20-1210]\] and after stroke \[[@b12-medscimonit-20-1210]--[@b14-medscimonit-20-1210]\].

Instrumented treadmills could be good measurement tools available to clinicians for monitoring the progress of training, and quantifying spatial and temporal gait parameters \[[@b15-medscimonit-20-1210],[@b16-medscimonit-20-1210]\]. For example, Kiss reported a strong correlation (r, 0.948--0.974) between instrumented treadmills and ultrasound-based measuring system \[[@b15-medscimonit-20-1210]\]. Wearing et al. reported a high correlation (r, 0.79--0.95) between the 2 measuring systems (instrumented treadmill *vs.* conventional instrumented walkway) despite systematic differences \[[@b17-medscimonit-20-1210]\]. One study using an instrument treadmill with healthy seniors reported high test-retest reliability \[[@b18-medscimonit-20-1210]\].

The OPTOGait system, which uses high-density photoelectric cells, was recently introduced. The system allows quantification of spatial and temporal gait parameters on essentially all flat surfaces. The OPTOGait system uses transmitting and receiving bars placed parallel to each other. When a subject passes between the transmitting bar and the receiving bar, the system detects any interruption in the light signal due to the presence of feet within the recording area, and automatically calculates the spatial and temporal gait parameters. The method has high concurrent validity and test-retest reliability compared to those of conventional instrumented walkway systems for over-ground walking \[[@b19-medscimonit-20-1210]\]. On the other hand, despite the availability in a clinical setting, the concurrent validity and reliability of treadmill-based gait analysis are unknown.

This study examined the concurrent validity and test-retest reliability of the OPTOGait system against the instrumented treadmill system by assessing the spatial and temporal gait parameters of stroke patients and healthy adults measured while walking at a comfortable speed.

Material and Methods
====================

Subjects
--------

Twenty-six stroke patients (age 65±4.6 years; 34 females, 20 males; height 164.9±5.8 cm; weight 64.3±8.4 kg) and 18 healthy young adults (age 28±.35 years; 9 females, 8 males; height 170.9±8.8 cm; weight 62.3±12.4 kg) were enrolled in this study. The stroke patients could walk independently on a treadmill for 10 min without gait aids or orthosis. The potential candidates needed to understand and act in accordance with simple spoken instructions. The healthy young adults had no medical history of cardiovascular, neurological, or orthopedic problems likely to affect their ability to walk on a treadmill. All protocols and procedures were approved by the Institutional Review Board of Sahmyook University and all subjects signed a statement of informed consent.

Instruments
-----------

The spatial and temporal gait parameters were collected using 2 commercially available systems: the OPTOGait photoelectric cells system (OPTOGait, Microgate S.r.I, Italy, 2010), and the Zebris instrumented gait analysis system (Zebris Medical GmbH, FDM-T system, Isny, Germany). The OPTOGait system used in this study consisted of a single transmitting bar and receiving bar positioned on the side bars of a treadmill (APSUN Inc, Korea) ([Figure 1](#f1-medscimonit-20-1210){ref-type="fig"}). Each single bar was 100×8 cm and contained 96 light diodes that were located 3 mm above floor level and approximately 1 cm apart. The data was extracted at 1000Hz and saved in a PC using OPTOGait Version 1.6.4.0 software (Microgate S.r.I, Italy).

The Zebris instrumented gait analysis system consisted of a capacitance-based foot pressure platform housed within a treadmill. The pressure platform had a sensing area of 112×49 cm and incorporated 3432 sensors. The treadmill had a contact surface of 210×70 cm, and its speed could be adjusted between 0.1 and 6 km/h at 0.1 km/h intervals. The data were obtained at a sampling rate of 100 Hz and saved in a PC using Win FDM-T Version 2.5.1 software (Zebris Medical GmbH, Germany).

Procedure
---------

Two researchers were responsible for system software and collecting data. General information, such as height and weight, was recorded. The subjects participated in the experiment wearing light-weight, comfortable clothing. The subjects were instructed to walk barefoot on the treadmill at their preferred walking speed. Prior to gait analysis, the subjects were allowed 10 min to become acquainted with treadmill walking \[[@b20-medscimonit-20-1210]\]. During the acclimatization session, the individual's preferred walking speed was measured and entered into the OPTOGait software. The participants were asked to walk on the treadmill again, and the treadmill speed was adjusted to match the self-selected walking speed determined during the acclimatization session. The spatio-temporal gait parameters were measured by placing the OPTOGait system on the Zebris treadmill system and operating both simultaneously. Once the participants were comfortable, a 60-s data capture period was used. Testing was repeated 30 min after the initial trial to evaluate the test-retest reliability.

Statistical analysis
--------------------

The spatio-temporal variables analyzed included the speed, cadence, gait cycle, step length, step time, stride length, duration of single and double limb support, and swing and stance phase duration. Statistical analysis was conducted using SPSS version 19.0 (SPSS Inc., Chicago, IL, USA). All measurements are expressed as the mean and standard deviation (SD). The differences between measurements systems with respect to the gait parameters were determined using a paired t-test. Paired t-tests were performed to determine the mean difference in the measurements for each gait variable recorded using the OPTOGait and Zebris treadmill system. The level of agreement between the OPTOGait and Zebris treadmill system was analyzed using the intra-class correlation coefficient (ICC \[2, 1\]) \[[@b21-medscimonit-20-1210]\]. For absolute comparisons of the parameters obtained in the 2 sessions, the coefficients of variation of the method errors (CV~ME~) \[[@b22-medscimonit-20-1210]\] and the 95% limits of agreement (LOA) described by Bland and Altman were calculated \[[@b23-medscimonit-20-1210]\]. The CV~ME~ values were converted to percentages by calculating the coefficients of variation of the method errors obtained using the standard deviations of the differences scores (S*d*) between the results obtained using the 2 systems (ME=S*d*/✓2, CV~ME~=2ME/(X1+X2)×100%).

The differences between the first and second sessions with respect to the gait parameters were determined using a paired t-test. The test-retest reliabilities of the gait parameters measured using the OPTOGait system are expressed as ICC (3, 1), and were described by Shrout and Flessiss. The CV~ME~ and 95% LOA \[[@b23-medscimonit-20-1210]\] were calculated for absolute comparisons of the parameters obtained during the 2 sessions. To estimate the absolute variability, the standard errors of measurement (SEMs) were calculated by measuring the range of errors for each gait parameter. The SEMs were calculated as (SD)×(1--ICC \[2, 1\])^1/2^ using the higher of the 2 SD measurements. For the convenience of interpretation, the SEMs are expressed as the percentage of the mean values (SEM%). In addition, the minimum detectable changes (MDC) at the confidence level of 95% were calculated to determine the smallest change needed to indicate a change as real and beyond the bounds of the measurement error. This was achieved by converting MDC to the percentage of the mean (MDC~95~%) after calculating it using the formula, ✓2×1.96×SEM \[[@b24-medscimonit-20-1210]\]. The absolute variability data was analyzed using Microsoft Excel^®^. The statistical significance was set at p\<0.05 for all procedures.

Results
=======

Concurrent validity
-------------------

[Table 1](#t1-medscimonit-20-1210){ref-type="table"} lists the mean and SD of the spatial and temporal gait parameters. A paired t-test was used to determine the systematic differences between the gait parameters obtained using the 2 systems. As a result, the step length and stride length of the OPTOGait system were significantly higher than those of the Zebris treadmill system in the stroke patients group. When expressed as a percentage of the gait cycle, the swing phase duration recorded by the OPTOGait system was significantly shorter than that of the Zebris treadmill system, whereas the stance phase of the OPTOGait system was significantly higher than that of the Zebris treadmill system. Furthermore, the period of the single limb support (SLS) phase of the OPTOGait system was significantly shorter than that of the Zebris treadmill system, whereas the total double limb support (TDLS) phase of the OPTOGait system was significantly greater than that of the Zebris treadmill system in both groups.

[Table 1](#t1-medscimonit-20-1210){ref-type="table"} lists the level of agreement between the OPTOGait and the Zebris treadmill system for each gait variable. In the young subjects, the ICCs for the spatial and temporal gait parameters were excellent (ICC \[2, 1\], 0.932\~0.999) but the temporal parameters expressed as a percentage of the gait cycle were poor (ICC \[2, 1\], 0.238\~0.468). The CV~ME~ values were small for all gait parameters (0.27\~7.18%). At 95% LOA, the spatial and temporal gait parameters were distributed in a symmetrical manner but the temporal parameters expressed as a percentage of the gait cycle were skewed to 1 side, except for the TDLS. In the stroke patients group, the ICCs were excellent for speed, cadence, gait cycle, step length, step time, and stride length (ICC \[2, 1\], 0.852\~0.990) and poor for the temporal parameters expressed as a percentage of the gait cycle (ICC \[2, 1\], 0.294\~0.319). The CV~ME~ values were relatively small for all gait parameters (1.15\~7.07%), except for TDLS% (10.05%). Scatter plots and Bland-Altman plots of the main spatial and temporal gait parameters provided by the OPTOGait system against the Zebris treadmill system are presented in [Figures 2](#f2-medscimonit-20-1210){ref-type="fig"} and [3](#f3-medscimonit-20-1210){ref-type="fig"}.

Test-retest reliability
-----------------------

[Tables 2](#t2-medscimonit-20-1210){ref-type="table"} and [3](#t3-medscimonit-20-1210){ref-type="table"} show the mean (SD) and test-retest reliability of the spatio-temporal gait parameters across the 2 measurement sessions obtained using the OPTOGait system in young and stroke subjects, respectively.

The paired t-test indicated that there were no significant systematic differences in any gait parameters between the 2 sessions in each group. In the young subjects, the ICCs for all the gait parameters were excellent (ICC \[3, 1\], 0.7745\~0.978). This was also reflected in the 95% LOA. All the gait parameters were distributed symmetrically. The CV~ME~ values were small for all gait parameters (0.89\~3.19%). For the 2 sessions, all the parameters showed a low level of SEM (0.36\~0.03%), indicating strong and absolute reliability. The MDC values (1.02\~5.63%) for all gait parameters indicated a low level of variation between the 2 sessions ([Table 2](#t2-medscimonit-20-1210){ref-type="table"}).

In the stroke patients group, the ICCs for all gait parameters were also excellent (ICC \[3, 1\], 0.854\~0.985). At 95% LOA, all spatial and temporal gait parameters were distributed in a symmetrical manner. The CV~ME~ values were small for all gait parameters (0.97\~3.56%). The SEM (0.19a\~1.17%) and the MDC (0.54\~3.24%) showed an absolutely strong reliability and a low level of variation between the 2 sessions, respectively ([Table 3](#t3-medscimonit-20-1210){ref-type="table"}).

Scatter plots and Bland-Altman plots of the main spatial and temporal gait parameters provided by OPTOGait session 1 and session 2 are presented in [Figures 4](#f4-medscimonit-20-1210){ref-type="fig"} and [5](#f5-medscimonit-20-1210){ref-type="fig"}.

Discussion
==========

Treadmill-based gait analysis was available to clinicians for monitoring the progress of training and quantifying the spatial and temporal gait parameters. However, there were many restrictions (e.g., space, experimental process, price, and portability) on the use of the equipment. On the other hand, the OPTOGait photoelectric cell system was the equipment available in both over-ground based and treadmill-based gait analysis, but the agreement was not clear with other equipment. Therefore, we investigated the concurrent validity and the test-retest reliability of the OPTOGait photoelectric cell system against the treadmill-based gait analysis system by assessing the spatio-temporal gait parameters in healthy young adults and stroke patients.

Systematic differences were observed in the temporal parameter expressed as a percentage of the gait cycle measured by the 2 systems in both groups. In the healthy young adults groups, the SLS phase (Left: 3.43%, Right: 3.32%) and swing phase duration (Left: 3.4%, Right 3.39%) recorded by the OPTOGait were shorter than the Zebris treadmill system, whereas the TDLS phase (6.8%) and stance phase duration (Left: 3.33%, Right: 3.18%) were longer. Similarly, in the stroke patients group, the SLS phase (Left: 3.41%, Right: 3.37%) and swing phase duration (Left: 2.94%, Right: 3.24%) recorded by the OPTOGait system were shorter than the Zebris treadmill system, whereas the TDLS phase (6.84%) and stance phase duration (Left: 2.94%, Right: 3.25%) were longer. The temporal differences were attributed to the LED diodes of the OPTOGait system being raised 3 mm higher from the floor. Therefore, the sensing of heel contact occurred earlier, and the sensing of toe lift-off occurred later than in the Zebris treadmill system in the gait cycle. In addition, there was a 3-mm gap between the Zebris pressure sensors under the treadmill belt and the OPTOGait diodes sensor on the treadmill sidebars. Another reason for the temporal difference was the difference in the measuring principle. The OPTOGait system detects the blocked segment and the time interval by sensing interruptions of the progression of light between the photoelectric diodes, whereas the Zebris pressure sensors identify the precise pressure threshold induced by a load. These temporal differences were reported in a comparative study of the OPTOGait system and force plate for an assessment of the vertical jump height, and of the OPTOGait system and portable walkway system for floor-based gait analysis \[[@b25-medscimonit-20-1210]\].

No significant differences in the spatial and temporal gait parameters (e.g., speed, cadence, gait cycle, step time, step length, and stride length) were observed. To assess the gait variables using the treadmill-based OPTOGait system, the walking speed must be entered into the software. In the present study, the walking speed was already calculated using the Zebris treadmill system during the acclimatization session and the same walking speed was also entered into the OPTOGait system.

The step length calculation process during treadmill walking was similar between the 2 systems. During continuous stepping on the treadmill belt at a constant speed, the OPTOGait system quantified the respective 1-dimensional data using the photoelectric cells, and the Zebris system was also quantified using a 1-dimensional ground reaction force measuring system. Measuring step length should be considered the anterio-posterior and the medio-lateral components according to the line of progression. Lienhard et al. reported that the weak point of a 1 dimensional gait evaluation could result in a substantial underestimation of the step length compared to the ground gait analysis systems that consider the line of progression, particularly in patients presenting large step widths \[[@b19-medscimonit-20-1210]\]. However, both systems did not consider the medio-lateral component of the gait in the measuring principle, so they quantified the value of the only anterio-posterior component of the step length parallel to the bars regardless of the individual walking direction.

The temporal parameters expressed as a percentage of the gait cycle in both healthy young adult group (ICC \<0.468) and stroke patient group (ICC \<0.319) showed a low correlation between the 2 systems. The CV% values were relatively higher (1.96\~7.18 in healthy young adult group, and 2.66\~10.05 in stroke patient group), and the 95% LOA values were skewed to 1 side compared to the other spatial and temporal parameters, indicating the presence of a systematic difference. On the other hand, the spatial and temporal gait parameters, such as speed, cadence, gait cycle, step time, step length, and stride length in both the healthy young group (ICC \>0.932) and the stroke patient group (ICC \>0.852) showed a strong correlation between the 2 systems. The CV% values were relatively lower (\<1.59% in the healthy young adult group, and \<3.83% in the stroke patient group respectively), and the 95% LOA values (including zero) were within a narrow range, with a symmetric distribution. These findings showed excellent agreement between the 2 measuring systems, with little systematic bias.

This study revealed high test-retest reliability and consistency with respect to the derivation of the spatial and temporal gait parameters of the healthy young adults group (ICC \>0.774) and the stroke patients group (ICC \>0.854) using the OPTOGait system. For all parameters, the ICCs indicated excellent test-retest reliability. Moreover, the CV% values for all parameters were 0.89\~2.79% and 0.97\~3.56%, and the 95% LOA values (including zero) were within a narrow range, with a symmetric distribution. These findings indicated that only slight differences were as important as the relative reliability. SEM is a quantitative expression of the range of errors that occur whenever the same participant repeated certain tests \[[@b26-medscimonit-20-1210]\]. In this study, SEM for the test-retest were converted to percentages of the mean values (SEM%), and showed a low measurement error (\<2.03% in he healthy young adult group, and \<1.17% in stroke patient group), indicating strong absolute reliability. The MDC was defined as the minimum change that could occur during the measurement, not due to accidental changes. Because it represents the degree of sensitivity to change, the MDC was needed to determine if the actual change occurred during the performance of the 2 sessions \[[@b27-medscimonit-20-1210]\]. This value could be a criterion for assessing the changes in a performed process. The MDC values in this study were relatively low (\<5.63% in the healthy young adult group, and \<3.24% in the stroke patient group) when expressed as a percentage of the means. Therefore, the measurements were sufficiently sensitive to the changes, suggesting that all spatial and temporal parameters measured using the OPTOGait system could be useful for sensing the changes that occurred in the gait process.

Unlike the over-ground gait, the treadmill gait encouraged the symmetry of steps \[[@b28-medscimonit-20-1210],[@b29-medscimonit-20-1210]\], allowed walking at a constant speed, and could collect many gait cycles and gait parameters. As a result of this study, the OPTOGait system and Zebris system showed excellent concurrent validity, and the treadmill-based OPTOGait had high test-retest reliability.

Conclusions
===========

This study compared the spatio-temporal gait parameters measured using the treadmill-based OPTOGait photoelectric cells system and the Zebris instrumented gait analysis system and examined the test-retest reliability of the spatial and temporal gait parameters using the OPTOGait system during treadmill walking with healthy young adults and stroke patients. Before measuring gait parameters using treadmill-based equipment, clinicians should first understand the characteristics of both systems and use each system only under the appropriate circumstances.

**Source of support:** This study was supported by Sahmyook University
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###### 

Mean (S.D.) and level of agreement of the gait parameters for subjects using the OPTOGait system and Zebris treadmill system.

  Gait parameters        Young subjects   Stroke patients                                                                                                                              
  ---------------------- ---------------- -------------------- ----------------------- ------ ----------------- --------------- -------------------- ------------------------- ------- ----------------
  Speed (m/s)            0.85 (0.08)      0.85 (0.08)          0.995 (0.990\~0.998)    0.63   −0.012\~0.014     0.71 (0.09)     0.72 (0.08)          0.908 (0.844\~0.946)      3.83    −0.033\~0.026
  Cadence (steps/m)      94.93 (8.67)     94.75 (8.75)         0.997 (0.994\~0.998)    0.50   −1.087\~0.665     97.60 (10.98)   97.63 (11.27)        0.988 (0.980\~0.993)      1.23    −1.987\~1.820
  Gait cycle (s)         1.28 (0.12)      1.28 (0.12)          0.999 (0.998\~1.000)    0.27   −0.006\~0.012     1.24 (0.14)     1.25 (0.15)          0.990 (0.983\~0.995)      1.15    −0.023\~0.039
  Lt. step (cm)          53.42 (3.24)     53.53 (3.33)         0.958 (0.920\~0.978)    1.25   −1.362\~1.807     44.76 (5.73)    44.50 (5.58)         0.975 (0.957\~0.986)      1.99    −2.542\~1.772
  Rt. step (cm)          53.66 (3.26)     53.58 (3.25)         0.932 (0.870\~0.965)    1.59   −2.406\~1.962     45.90 (5.18)    45.53 (4.86)         0.947 (0.910\~0.969)      2.42    −3.193\~1.943
  Lt. step time (s)      0.64 (0.06)      0.64 (0.06)          0.990 (0.981\~0.995)    0.96   −0.008\~0.018     0.61 (0.08)     0.62 (0.08)          0.958 (0.928\~0.976)      2.67    −0.019\~0.027
  Rt. step time (s)      0.64 (0.06)      0.64 (0.06)          0.985 (0.971\~0.992)    1.14   −0.020\~0.015     0.61 (0.08)     0.62 (0.08)          0.852 (0.756\~0.912)      5.01    −0.012\~0.027
  Stride (cm)            106.97 (5.54)    107.00 (6.12)        0.969 (0.939\~0.984)    0.97   −1.986\~2.319     90.64 (9.01)    89.98 (8.69)         0.976 (0.959\~0.986)      1.51    −5.017\~2.575
  Lt. SLS (%)            31.39 (1.69)     34.82 (1.50)\*\*\*   0.370 (0.052\~0.620)    3.83   −0.165\~7.143     29.79 (2.25)    33.20 (2.00)\*\*\*   0.297 (0.029\~0.525)      5.68    −1.378\~7.987
  Rt. SLS (%)            31.44 (1.64)     34.76 (1.36)\*\*\*   0.238 (−0.099\~0.526)   3.92   0.026\~7.074      29.63 (2.27)    33.00 (2.39)\*\*\*   0.098 (−0.177\~0.359)     7.07    −2.811\~9.386
  TDLS (%)               37.19 (3.21)     30.39 (2.60)\*\*\*   0.310 (−0.016\~0.577)   7.18   −13.975\~−0.158   40.64 (3.91)    33.80 (2.41)\*\*\*   −0.294 (−0.523\~−0.026)   10.05   −16.894\~3.571
  Lt. swing phase (%)    31.44 (1.62)     34.84 (1.44)\*\*\*   0.243 (−0.088\~0.526)   4.02   −0.047\~7.147     29.98 (2.35)    32.92 (2.31)\*\*\*   0.042 (−0.232\~0.309)     7.20    −3.596\~9.061
  Rt. swing phase (%)    31.38 (1.70)     34.77 (1.43)\*\*\*   0.378 (0.061\~0.626)    3.75   −0.097\~7.109     30.07 (2.32)    33.31 (2.06)\*\*\*   0.315 (0.048\~0.539)      5.78    −1.358\~8.206
  Lt. stance phase (%)   68.56 (1.62)     65.23 (1.37)\*\*\*   0.239 (−0.093\~0.523)   1.96   −7.165\~0.077     70.02 (2.35)    67.09 (2.32)\*\*\*   0.041 (−0.232\~0.308)     3.32    −9.063\~3.605
  Rt. stance phase (%)   68.36 (2.15)     65.18 (1.49)\*\*\*   0.468 (0.169\~0.688)    2.02   −7.139\~0.627     69.93 (2.32)    66.68 (2.05)\*\*\*   0.319 (0.053\~0.543)      2.66    −8.000\~1.344

ICC-- intra correlation coefficient; CVME -- coefficients of variation of method error; LOA -- limits of agreement; SLS -- single limb support; TDLS -- total double limb support. Significant difference between the two measuring instruments (\*\*\*, p≤0.001).

###### 

Mean (S.D.) and test-retest reliability of the gait parameters for the two measurement sessions in healthy young adults.

  Gait parameters        Session 1       Session 2       ICC (95% CI)           95% LOA         CV %   SEM %   MDC %
  ---------------------- --------------- --------------- ---------------------- --------------- ------ ------- -------
  Speed (m/s)            0.84 (0.07)     0.85 (0.07)     0.978 (0.943--0.992)   −0.026\~0.037   1.35   2.03    5.63
  Cadence (steps/m)      95.13 (8.35)    94.73 (9.21)    0.962 (0.901--0.948)   −5.173\~4.373   1.81   0.37    1.02
  Gait cycle (s)         1.27 (0.11)     1.27 (0.13)     0.961 (0.900--0.985)   −0.057\~0.073   1.84   0.40    1.11
  Lt. step (cm)          53.44 (2.91)    53.39 (3.42)    0.805 (0.668--0.929)   −5.101\~4.324   3.19   1.89    5.24
  Rt. step (cm)          54.22 (3.84)    54.55 (3.61)    0.835 (0.613--0.935)   −3.865\~4.532   2.78   1.17    3.23
  Lt. step time (s)      0.64 (0.06)     0.64 (0.07)     0.920 (0.799--0.969)   −0.049\~0.050   2.79   0.88    2.43
  Rt. step time (s)      0.64 (0.07)     0.64 (0.06)     0.940 (0.848--0.977)   −0.050\~0.043   2.58   0.66    1.82
  Stride (cm)            106.28 (4.46)   107.66 (6.49)   0.812 (0.566--0.925)   −5.035\~8.083   2.25   1.14    3.16
  Lt. SLS (%)            31.31 (1.52)    31.47 (1.89)    0.873 (0.694--0.951)   −1.527\~1.861   1.94   0.76    2.12
  Rt. SLS (%)            31.15 (1.50)    31.74 (1.71)    0.857 (0.658--0.944)   −1.100\~2.277   1.93   0.78    2.15
  TDLS (%)               37.56 (2.93)    36.81 (3.52)    0.911 (0.778--0.966)   −3.430\~1.930   2.60   0.84    2.34
  Lt. swing phase (%)    31.17 (1.51)    31.72 (1.72)    0.855 (0.655--0.943)   −1.151\~2.262   1.95   0.79    2.20
  Rt. swing phase (%)    31.29 (1.53)    31.46 (1.89)    0.872 (0.691--0.950)   −1.548\~1.870   1.96   0.77    2.14
  Lt. stance phase (%)   68.84 (1.52)    68.28 (1.71)    0.856 (0.657--0.944)   −2.265\~1.142   0.89   0.36    1.00
  Rt. stance phase (%)   68.72 (1.52)    68.28 (2.31)    0.774 (0.492--0.909)   −3.018\~2.140   1.35   0.76    2.11

ICC -- intra correlation coefficient; LOA -- limits of agreement; CVME -- coefficients of variation of method error; SEM -- standard error of measurement; MDC -- minimum detectable change; SLS -- single limb support; TDLS -- total double limb support.

###### 

Mean (S.D.) and test-retest reliability of the gait parameters for the two measurement sessions in stroke patients.

  Gait parameters        Session 1       Session 2       ICC (95% CI)           95% LOA         CV %   SEM %   MDC %
  ---------------------- --------------- --------------- ---------------------- --------------- ------ ------- -------
  Speed (m/s)            0.71 (0.10)     0.71 (0.10)     0.966 (0.926--0.985)   −0.049\~0.051   2.97   0.47    1.31
  Cadence (steps/m)      97.65 (11.36)   97.56 (10.81)   0.970 (0.935--0.986)   −5.408\~5.224   2.27   0.35    0.97
  Gait cycle (s)         1.23 (0.15)     1.23 (0.14)     0.962 (0.918--0.983)   −0.080\~0.076   2.52   0.46    1.28
  Lt. step (cm)          44.56 (5.76)    44.96 (5.80)    0.985 (0.968--0.996)   −1.537\~2.344   1.63   0.19    0.54
  Rt. step (cm)          45.99 (5.35)    45.81 (5.11)    0.929 (0.848--0.967)   −4.060\~3.694   3.18   0.83    2.29
  Lt. step time (s)      0.61 (0.07)     0.61 (0.08)     0.911 (0.812--0.959)   −0.067\~0.066   3.54   1.17    3.24
  Rt. step time (s)      0.61 (0.08)     0.61 (0.08)     0.926 (0.843--0.966)   −0.063\~0.064   3.56   0.97    2.69
  Stride (cm)            90.45 (9.28)    90.83 (8.90)    0.973 (0.941--0.988)   −3.750\~4.520   1.86   0.28    0.77
  Lt. SLS (%)            29.73 (2.34)    29.85 (2.20)    0.901 (0.792--0.954)   −1.855\~2.117   2.61   0.78    2.16
  Rt. SLS (%)            29.55 (2.26)    29.71 (2.31)    0.949 (0.890--0.977)   −1.279\~1.586   1.78   0.40    1.10
  TDLS (%)               40.74 (4.12)    40.52 (3.89)    0.957 (0.907--0.980)   −2.529\~2.083   2.49   0.44    1.21
  Lt. swing phase (%)    30.01 (2.23)    30.12 (2.44)    0.920 (0.830--0.963)   −1.730\~1.940   2.21   0.65    1.80
  Rt. swing phase (%)    29.91 (2.35)    30.04 (2.39)    0.854 (0.701--0.932)   −2.378\~2.647   3.25   1.16    3.23
  Lt. stance phase (%)   69.98 (2.23)    69.87 (2.44)    0.920 (0.830--0.963)   −1.940\~1.730   0.97   0.28    0.77
  Rt. stance phase (%)   70.09 (2.34)    69.95 (2.39)    0.854 (0.701--0.932)   −2.647\~2.378   1.41   0.50    1.38

ICC -- intra correlation coefficient; LOA -- limits of agreement; CVME -- coefficients of variation of method error; SEM -- standard error of measurement; MDC -- minimum detectable change; SLS -- single limb support; TDLS -- total double limb support.
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